期刊文献+

结直肠腺癌中特异蛋白1表达与临床病理指标的关系 被引量:1

Relationship between expression of specificity protein 1 of colorectal adenocarcinoma and clinicopathological parameters
下载PDF
导出
摘要 目的研究结直肠腺癌组织中特异蛋白1(Sp1)表达的变化及其与患者临床病理学指标的关系。方法通过查阅mRNA array数据库Oncomine,分析结直肠腺癌组织及正常组织中Sp1 mRNA的水平和差异。采用免疫组织化学法检测65例结直肠腺癌组织及其癌旁正常组织中Sp1蛋白的表达,Western blotting检测5个不同恶性程度的结直肠癌细胞系中Sp1蛋白的表达,分析Sp1表达水平与结直肠癌患者临床病理学指标之间的关系。结果查阅Oncomine数据库发现Sp1 mRNA在结直肠腺癌组织中的表达与正常组织无明显差异。免疫组织化学法及细胞系Western blotting检测结果证实,Sp1在结直肠腺癌组织和细胞系中均有较高的一致性表达,但与癌旁正常组织无差异;肿瘤组织中Sp1蛋白表达水平与结直肠腺癌患者淋巴结和远处转移与否无明显相关性。结论转录因子Sp1在结直肠腺癌组织中的表达与正常组织无明显差异,与肿瘤转移无明显相关性。 Objective To investigate the expression changes of specificity protein 1 (Spl) in colorectal adenocarcinoma tissues and its relationship with the clinicopathological parameters of patients. Methods The levels and differences of Spl mRNA of colorectal adenocarcinoma tissues and normal tissues were analyzed by retrieving the mRNA array database of Oncomine. The expression of Spl protein of 65 colorectal adenocarcinoma tissues and adjacent normal tissues was detected by the immunohistochemistry (IHC) assay. The expression of Spl protein of colorectal cancer ceil lines of 5 different malignant degrees was detected by the Western blotting. The relationship of the expression level of Sp1 and the clinicopathological parameters of patients with colorectal adenocarcinoma was analyzed. Results There was no significant difference of Sp1 mRNA level between colorectal adenocarcinoma tissues and normal tissues according to the mRNA array database of Oncomine. The results of immunohistochemistry and Western blotting showed that the expressions of Sp1 of colorectal adenocarcinoma tissues and cell lines were highly consistent, but were not different from those of adjacent normal tissues. There was no significant correlation between the expression level of Sp1 protein of colorectal adenocarcinoma tissues and lymph node metastasis, as well as distant metastasis. Conclusion The expression of Sp1 of colorectal adenocarcinoma tissues is not significantly different from that of normal tissues and is not significandy correlated to the cancer metastasis.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第7期973-977,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(81072171)~~
关键词 特异蛋白1 结直肠腺癌 Oncomine数据库 免疫组织化学 结直肠癌细胞系 specificity protein 1 colorectal adenocarcinoma Oncomine database immunohistochemistry colorectal cancer cell lines
  • 相关文献

参考文献4

二级参考文献30

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2王春雷,黄志强,万远廉,刘玉村.TGF-β1对人肝癌细胞系凋亡的调控作用研究(英文)[J].现代肿瘤医学,2006,14(2):176-178. 被引量:3
  • 3潘奇,王鲁,孙惠川,刘银坤,叶胜龙,汤钊猷.不同转移潜能人肝癌细胞系转录因子活性差异分析[J].中华肝脏病杂志,2006,14(1):37-40. 被引量:21
  • 4Xie K,Wei D,Huang S.Transcriptional anti-angiogenesis therapy of human pancreatic cancer[J].Cytokine Growth Factor Rev,2006,17:147-156.
  • 5Yuan P,Wang L,Wei D,et al.Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer[J].Cancer,2007,110:2682-2690.
  • 6Higgins KJ,Abdelrahim M,Liu S,et al.Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins[J].Biochem Biophys Res Commun,2006,34:292-301.
  • 7Jiang NY,Woda BA,Banner BF,et al.Sp1,a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma[J].Cancer Epidemiol Biomarkers Prev,2008,17:1648-1652.
  • 8Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 9Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 10Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.

共引文献206

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部